1. US Department of Health and Human Services; Food and Drug Administration; Center for Drug Evaluation and Research (CDER); Center for Biologics Evaluation and Research (CBER) Guidance for Industry Expedited Programs for Serious Conditions - Drugs and Biologics http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm358301.pdf
2. Trends in utilization of FDA expedited drug development and approval programs, 1987-2014: cohort study;Kesselheim;BMJ,2015
3. Picking up the pace;Yandell;The Scientist
4. Parkinson disease psychosis: update;Friedman;Behav Neurol,2013
5. Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 1: pathophysiology and mechanisms of induction;Margolese;Can J Psychiatry,2005